News and Trends 26 Sep 2022 Cuba to receive €46.7M to boost biopharma sector …vital importance for the development of this initiative.” The project, which will be executed by the United Nations Development Program (UNDP), in accordance with its procurement policies and regulations, will… September 26, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 11 Sep 2017 Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech …European biotech then — comparatively shallow pockets? I think you need a mix of investors for other reasons. Biotech was built up in the United States, so American investors tend… September 11, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2017 The EU Approves New Treatment for a Rare Pediatric Cancer …but targeting the anti-GD2 antibody is actually not new. US-based United Therapeutics‘ anti-GD2 antibody Unituxin was approved by the EMA for the treatment of neuroblastoma in patients aged 12 months… May 8, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2023 Triastek sees positive results from printed oral treatment for ulcerative colitis …application for T21 from the United States Food and Drug Administration (FDA). The original drug is an oral Janus kinase (JAK) inhibitor called tofacitinib. Following the approval of T21, Triastek… July 25, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Apr 2023 Orphalan announces U.S. launch of drug to treat Wilson disease …available for the treatment of adult patients with stable Wilson disease who are de-coppered and tolerant to D-penicillamine. Cuvrior was approved by the United States Food and Drug Administration (FDA)… April 21, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2022 Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorization …acquired the global rights to NULIBRY and is responsible for the ongoing development and commercialization of NULIBRY in the United States and developing, manufacturing, and commercializing fosdenopterin globally. Sentynl and BridgeBio share… July 25, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2023 Evotec receives $6.6M for tuberculosis drug discovery …continue and expand our commitment to global health, to make a meaningful contribution to achieve targets set under the United Nation Sustainable Development Goal (SDG) No 3 and to enable… March 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by Thermo Fisher Scientific 20 Feb 2024 More sustainable drug development and lab sustainability …the United Nations as “meeting the needs of the present without compromising the ability of future generations to meet their own needs.” Sustainability is influenced by many factors and not… February 20, 2024 - 6 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2016 Merck and Sigma-Aldrich: Together to solve the toughest problems in life science …of Merck, which operates as MilliporeSigma in the United States and Canada, is a global leader in the $125 billion life science industry. Its purpose is to solve the toughest… July 25, 2016 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2022 Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors Regen BioPharma, Inc. has filed with the United States Patent and Trademark Office a provisional U.S. patent application covering the company’s novel approach for enabling chimeric antigen receptor (CAR)-T cell-based… August 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Aug 2022 PharmAla Biotech files patent applications for MDMA analogs Canadian company PharmAla Biotech has filed a key patent cooperation treaty (PCT) application, containing six novel chemical entities (NCEs). The application claims priority to, and benefit of a United States… August 29, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Sep 2025 Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? …and animals are currently threatened with extinction, according to a report by the United Nations Environment Programme in 2022. With global funding shortages, including U.S. cuts to conservation nonprofits imposed… September 24, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email